Company / Cash per Share
NovaBay Pharmaceuticals, Inc. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.09
FY2024
5-year range
$0.09 / $2.63
FY2020-FY2024
Trend
-66.2%
vs FY2023
Sector context
#204 of 207
Health Care
What the data says
Among 207 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 1% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2024 to $2.73 in FY2016.
Based on SEC 10-K filings.
0.09 in FY2024 with a 5-year CAGR of -22.8%.
Declined from $2.63 to $0.09 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -22.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 207This company $0.09 Sector average $67.39
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, cash per share decreased 66.2% year-over-year.
- Ranks #204 out of 207 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.09 | -66.2% |
| FY2023 | $0.26 | -90.1% |
| FY2022 | $2.63 | +1432.9% |
| FY2021 | $0.17 | -49.6% |
| FY2020 | $0.34 | +6.3% |
| FY2019 | $0.32 | +71.8% |
| FY2018 | $0.19 | -10.9% |
| FY2017 | $0.21 | -92.3% |
| FY2016 | $2.73 | +136.4% |
| FY2015 | $1.15 | +848.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026